Gmx-LB Capsule is a combination pharmaceutical formulation containing Amoxycillin 500 mg and Lactobacillus spores equivalent to 1.66 billion viable units per capsule. Amoxycillin, a broad-spectrum beta-lactam antibiotic, is effective against a wide range of gram-positive and gram-negative bacterial infections by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The inclusion of Lactobacillus, a probiotic, helps restore and maintain the natural balance of intestinal flora, which can be disrupted during antibiotic therapy. This synergistic combination is particularly useful in the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections where antibiotic-associated dysbiosis is a concern. Gmx-LB Capsule should be administered as prescribed by a healthcare professional, typically taken orally with or without food. Caution is advised in patients with a history of hypersensitivity to penicillins or probiotics. The probiotic component may help reduce the incidence of antibiotic-associated diarrhea and improve gut health during and after antibiotic treatment. It is important to complete the full prescribed course to prevent the development of antibiotic resistance. Storage should be in a cool, dry place away from direct sunlight.